An Open-Label, 18FDG-PET Pharmacodynamic Assessment of the Effect of BIIB021 in Subjects With Gastrointestinal Stromal Tumors (GIST) - Related Studies

An Open-Label, 18FDG-PET Pharmacodynamic Assessment of the Effect of BIIB021 in Subjects With Gastrointestinal Stromal Tumors (GIST)

This study is currently recruiting participants.

Study NCT00618319. Last updated on October 21, 2008. Information provided by Biogen Idec

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		GIST

2	Additional conditions recognized in this trial
		Gastrointestinal Stromal Tumors

3	More general conditions related to this trial
		Digestive System Diseases
		Digestive System Neoplasms
		Gastrointestinal Diseases
		Gastrointestinal Neoplasms
		Neoplasms
		Neoplasms by Site

4	Interventions listed in this trial
		BIIB021

5	Sponsors listed in this trial
		Biogen Idec